List of Studies ( Metabolite:3-Methylsuberic acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004200 | AN006985 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST004200 | AN006986 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST004153 | AN006895 | Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model | Feces | Rat | Shanghai Jiao Tong University | LC-MS | |
| ST003817 | AN006276 | Irisin promotes bone tissue repair and intestinal protection in osteoporotic mice | Feces | Mouse | Osteoporosis | Huizhou Central People's Hospital | LC-MS |
| ST003307 | AN005418 | Untargeted metabolomics of rhizosphere soil from 4-years Panax ginseng that was treated with endo-borneol under field condition | Soil | Panax ginseng | Yunnan University | LC-MS | |
| ST002761 | AN004490 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | LC-MS | |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000670 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000666 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000083 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000078 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
